Home Pilots AION Labs launches CombinAble.AI to design antibodies for therapeutic development Pilots AION Labs launches CombinAble.AI to design antibodies for therapeutic development By - March 15, 2024 81 0 Facebook Twitter Pinterest WhatsApp The Israel-based company is the result of AION Labs’ fifth startup challenge. RELATED ARTICLESMORE FROM AUTHOR Pilots Former Ripple exec Greg Kidd buys Know Labs with Bitcoin Pilots RadNet acquires See-Mode Technologies for access, revenue growth Pilots FDA launches AI tool for its employees LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Exclusive: General Catalyst-backed Blackwell Security garners $13M Pilots - May 7, 2024 0 Google reveals new offerings, advancements in LLMs/AI during Check Up event Pilots - March 19, 2024 0 Socially Determined and Datavant partner on SDOH data Pilots - January 19, 2023 0 Vuzix tries out smart glasses for emergency medical care in Japan Pilots - August 17, 2022 0 Alphabet’s Verily raises $1B to expand precision health business Pilots - September 12, 2022 0 POPULAR CATEGORIESPilots2369Applications835Testing285Collaborations15GitHub3